Peer-Reviewed Publication

Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy

September 1, 2022

Download

Published in: Cancer Treatment Reviews

Jeffrey M. Conroy

Cancers & tumors Immunotherapy Biomarkers Proteins Cancer Treatment Reviews Oncology Personalized & precision